Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yannis Hadjiyannis"'
Autor:
Yannis Hadjiyannis, Cecelia Miller, Norris I. Hollie, Jayalakshmi Balakrishna, Francesca Cottini
Publikováno v:
Journal of Hematology. 12:49-58
Autor:
Yasmine Belkaid, Michail S. Lionakis, Mukil Natarajan, Olle Kämpe, Åsa Hallgren, Ehsan Chitsaz, David E. Kleiner, Theo Heller, Rabab Ali, Elise M. N. Ferré, Sungyoung Auh, Yannis Hadjiyannis, David M. Chascsa, Jamie Marko, Thomas L. Simcox, Christopher Koh, Stacey R. Rose, Hawwa Alao, Mariam Quinones
Publikováno v:
Hepatology
Background and aims Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), caused by autoimmune regulator (AIRE) mutations, manifests with chronic mucocutaneous candidiasis (CMC) and multisystem autoimmunity, most often hypoparathyr
Autor:
Shaaron Ochoa-Rios, Ian P. O'Connor, Lindsey N. Kent, Julian M. Clouse, Yannis Hadjiyannis, Christopher Koivisto, Thierry Pecot, Peggi M. Angel, Richard R. Drake, Gustavo Leone, Anand S. Mehta, Don C. Rockey
Publikováno v:
Molecular and Cellular Proteomics
Molecular and Cellular Proteomics, 2022, pp.100225. ⟨10.1016/j.mcpro.2022.100225⟩
Molecular and Cellular Proteomics, 2022, pp.100225. ⟨10.1016/j.mcpro.2022.100225⟩
International audience; Non-alcoholic steatohepatitis (NASH) is the progressive form of non-alcoholic fatty liver disease (NAFLD) and is characterized by inflammation, hepatocyte injury, and fibrosis. Further, NASH is a risk factor for cirrhosis and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c39a8e49e9e9d26855ba47c2e00e339
https://hal.science/hal-03632535/document
https://hal.science/hal-03632535/document
Autor:
Michail S. Lionakis, Theo Heller, Elise M. N. Ferré, Jeremy L. Davis, Monica M. Schmitt, Yannis Hadjiyannis
Publikováno v:
Am J Gastroenterol
Autor:
James M. Pipas, Kamal S. Pohar, Soledad Fernandez, Bart Westendorp, Alain de Bruin, Sooin Bae, Miguel Pérez, Grace C. Miller, Eric Nolan, Raleigh D. Kladney, Elisa Ridolfi, Shih-Yin Tsai, Gustavo Leone, Xing Tang, Chelsea K. Martin, Thomas J. Rosol, Arunima Srivastava, Emilia Plevris, Yannis Hadjiyannis, Lindsey N. Kent, Christopher Koivisto, Sarah M. Zorko
Publikováno v:
CLIN Journal, 127(3), 830-842. AMER SOC CLINICAL INVESTIGATION INC
Journal of Clinical Investigation, 127(3), 830. The American Society for Clinical Investigation
Journal of Clinical Investigation, 127(3), 830. The American Society for Clinical Investigation
Disruption of the retinoblastoma (RB) tumor suppressor pathway, either through genetic mutation of upstream regulatory components or mutation of RB1 itself, is believed to be a required event in cancer. However, genetic alterations in the RB-regulate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::645d8db77d84268993a7ba1afdcd94d9
https://research.rug.nl/en/publications/450f5799-42ef-4889-a2c3-943f34a1d746
https://research.rug.nl/en/publications/450f5799-42ef-4889-a2c3-943f34a1d746